Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-06

FDA Approved: BUMETANIDE — Supplemental Application (NorthStar Rx, LLC)

View source ↗

Summary

The FDA approved a supplemental application for bumetanide submitted by NorthStar Rx, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

SUPPL AP for BUMETANIDE (BUMETANIDE)